PharmaCyte Biotech Board of Directors Announces Business Rev

07.10.2022 - Topics to Include Continued Analysis of FDA’s Clinical Hold on IND for Cell-in-a-BoxLAS VEGAS, Oct. 07, 2022 (GLOBE NEWSWIRE) - PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), a biotechnology company focused on evaluating ... Seite 1

Related Keywords

Kennethl Waggoner , Joshuan Silverman , , Business Review Committee , Pharmacyte Biotech Inc , Drug Administration , Nasdaq , Include Continued Analysis , Cyte Biotech ,